These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1383634)
1. Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captopril. Fossa AA; Weinberg LJ; Barber RL; Rauch AL; Nocerini MR; Murphy WR; Swindell AC J Cardiovasc Pharmacol; 1992 Jul; 20(1):75-82. PubMed ID: 1383634 [TBL] [Abstract][Full Text] [Related]
2. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
3. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma renin activity and hypotensive effect of captopril in dogs. Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension. Azizi M; Guyene TT; Chatellier G; Ménard J J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
7. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related]
8. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
9. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients. Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973 [TBL] [Abstract][Full Text] [Related]
10. Effect of renin inhibitor, ES-8891, on renal renin secretion and storage in the marmoset: comparison with captopril. Ii Y; Murakami E; Hiwada K J Hypertens; 1991 Dec; 9(12):1119-25. PubMed ID: 1663967 [TBL] [Abstract][Full Text] [Related]
11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
13. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure. Nekooeian AA; Ogilvie RI; Zborowska-Sluis D Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666 [TBL] [Abstract][Full Text] [Related]
14. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca. Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of the primate-selective renin inhibitor, A-62198. Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep. Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038 [TBL] [Abstract][Full Text] [Related]
17. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516 [TBL] [Abstract][Full Text] [Related]
19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics. Chan PS; Ronsberg MA; Cervoni P Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of captopril induced hypotension in rats. Clarke DE; Wagner LB; Wagner LA Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]